2nd Quarter - Report
FARRAGUT PARTNERS LLP for GENENTECH
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B reforms). 21st century cures 2.0 legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN BAUTZ | Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz |
| JODY SHINTARO GALE | — |
| WILLIAM KRIEGER | — |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) |
| DYLAN MOORE | Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8) |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux |
| EDWARD WHITFIELD | U.S. Representative (21 yrs.) |
Health Issues HCR
Issues related to the 340B Drug discount program. Drug Pricing Proposals. Issues related to drug pricing. 21st century cures 2.0 legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN BAUTZ | Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz |
| JODY SHINTARO GALE | — |
| WILLIAM KRIEGER | — |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) |
| DYLAN MOORE | Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8) |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux |
| EDWARD WHITFIELD | U.S. Representatives (21 yrs.) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.